Shopping Cart
Remove All
Your shopping cart is currently empty
Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, inhibiting the macrophage colony-stimulating factor pathway upstream components, used in retinal disease research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $328 | In Stock | In Stock | |
| 5 mg | $1,160 | In Stock | In Stock | |
| 10 mg | $1,860 | - | In Stock | |
| 25 mg | $2,770 | - | In Stock | |
| 50 mg | $3,730 | - | In Stock |
| Description | Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, inhibiting the macrophage colony-stimulating factor pathway upstream components, used in retinal disease research. |
| In vivo | Treatment of NOD/SCID mice with anti-human CSF-1 mAb Lacnotuzumab by subcutaneous injection of CHLA-255-Fluc NBs (given alone once weekly) reduced human monocyte-derived CD163 + cells but did not improve chemotherapy. [2] |
| Synonyms | MCS110, MCS 110, Anti-Human B7-H3 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | CSF1/M-CSF |
| Molecular Weight | 144.8 kDa |
| Cas No. | 1831128-32-5 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.